Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis.

Tunis SR, Sheinhait IA, Schmid CH, Bishop DJ, Ross SD.

Clin Ther. 1997 Jul-Aug;19(4):743-57.

PMID:
9377618
2.
4.
6.

Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.

Tsuji S, Kawano S, Higashi T, Mukuda T, Imaizumi T, Tatsumi T, Miura N, Miyajima K, Fukuda M, Noguchi M, et al.

J Clin Gastroenterol. 1995;20 Suppl 2:S1-4.

PMID:
7594320
7.

Effect of lansoprazole on peptic ulcers.

Ohashi T, Sakata J, Haraguchi Y, Eto T.

J Clin Gastroenterol. 1995;20 Suppl 2:S83-5.

PMID:
7594350
8.

Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.

Spinzi GC, Bierti L, Bortoli A, Colombo E, Fertitta AM, Lanzi GL, Venturelli R, Minoli G.

Aliment Pharmacol Ther. 1998 May;12(5):433-8.

9.

Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers.

Arkkila PE, Seppälä K, Kosunen TU, Sipponen P, Mäkinen J, Rautelin H, Färkkilä M.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):93-101.

PMID:
15647648
10.

Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.

Graham DY, Hammoud F, El-Zimaity HM, Kim JG, Osato MS, El-Serag HB.

Aliment Pharmacol Ther. 2003 May 15;17(10):1229-36.

11.

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.

Campbell DR, Haber MM, Sheldon E, Collis C, Lukasik N, Huang B, Goldstein JL.

Am J Gastroenterol. 2002 Sep;97(9):2208-14.

PMID:
12358234
12.

Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.

Am J Gastroenterol. 1997 Mar;92(3):429-37.

PMID:
9068463
13.

Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.

Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, Saccà N, Frandina C, Fiocca R, Trimboli V, Pallone F.

Clin Ther. 2001 May;23(5):761-70.

PMID:
11394734
14.

The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.

Sasakii M, Joh T, Yokoyama Y, Seno K, Tsuchida K, Kurokawa T, Itoh M.

J Pharm Pharmacol. 1999 Jul;51(7):825-30.

PMID:
10467958
15.

Lansoprazole: an update of its place in the management of acid-related disorders.

Matheson AJ, Jarvis B.

Drugs. 2001;61(12):1801-33. Review.

PMID:
11693467
16.

Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.

Bazzoli F, Pozzato P, Zagari M, Fossi S, Ricciardiello L, Nicolini G, Berretti D, De Luca L.

Helicobacter. 1998 Sep;3(3):195-201.

PMID:
9731991
17.
18.

Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.

Sakaguchi M, Ashida K, Umegaki E, Miyoshi H, Katsu K.

J Clin Gastroenterol. 1995;20 Suppl 2:S27-31.

PMID:
7594334
19.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
20.

Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses.

Gremse DA.

Expert Opin Pharmacother. 2001 Oct;2(10):1663-70. Review.

PMID:
11825309

Supplemental Content

Support Center